Even though there is no previous evidence in the literature for CCL7 abolishing immunoglobulin expression specifically during cancer progression, it was reported that MSC–derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction [21]. The gene discussed is PAX5; the disease is cancer.